Bristol Myers Squibb (BMY) Tops Q3 Earnings and Revenue EstimatesZacks Investment Research • 10/31/24
Bristol Myers's stock pops as earnings top estimates and company raises guidanceMarket Watch • 10/31/24
Bristol Myers Earnings Top Q3 Estimates; Pharma Giant Raises GuidanceInvestors Business Daily • 10/31/24
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugsCNBC • 10/31/24
Curious about Bristol Myers (BMY) Q3 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 10/28/24
Bristol Myers Squibb to Present New Clinical and Health Economics and Outcomes Research Data at Psych Congress 2024Business Wire • 10/28/24
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock UpsideBenzinga • 10/17/24
A Market Crash Could Ruin Baby Boomers: 5 Safe High-Yield Dividend Stocks and Advice24/7 Wall Street • 10/16/24
Bristol Myers Squibb (BMY) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks Investment Research • 10/11/24
U.S. Food and Drug Administration Approves Perioperative Treatment of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Single-Agent Opdivo for Resectable Non-Small Cell Lung Cancer (NSCLC)Business Wire • 10/03/24
Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines PipelineBenzinga • 09/30/24